LONDON and MUNICH and NEW DELHI, Jan. 21, 2025 /PRNewswire/ -- Datar Cancer Genetics (DCG) today announced the launch of Target-MRD, an advanced molecular residual disease (MRD) monitoring blood ...

Datar Cancer Genetics (DCG) has launched the Target-MRD blood test, designed for the identification and monitoring of molecular residual disease (MRD) in individuals with solid organ cancers.

Three female Israeli hostages held by Hamas in Gaza for 15 months have been released and brought back to Israel, after a long-awaited ceasefire deal took effect. Romi Gonen, Doron Steinbrecher ...

London [UK]/ Munich [Germany]/ New Delhi [India], January 22: Datar Cancer Genetics (DCG) today announced the launch of Target-MRD, an advanced molecular residual disease (MRD) monitoring blood ...

Thus, it is important that every Government resists the temptation to ignore these conventions for short-term gains or to settle political scores. Arvind P. Datar is a Senior Advocate.

Datar Cancer Genetics (DCG), a Maharashtra-based diagnostic centre, has introduced Exacta AI, an AI-powered multi-analyte platform designed to optimise treatment options for cancer patients. The ...

$ 0.001 USD 0.00 0.00% ...